Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014 (2014), Article ID 798078, 16 pages
http://dx.doi.org/10.1155/2014/798078
Research Article

Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas’ Heart Disease

1Laboratório de Biologia das Interações, Instituto Oswaldo Cruz/Fiocruz, Avenida Brasil 4365, 21045-900 Rio de Janeiro, RJ, Brazil
2Departamento de Patologia, Universidade Federal Fluminense, 24033-900 Niterói, RJ, Brazil
3Laboratório de Biologia Molecular e Doenças Endêmicas, IOC/Fiocruz, 21045-900 Rio de Janeiro, RJ, Brazil

Received 14 April 2014; Revised 24 June 2014; Accepted 26 June 2014; Published 22 July 2014

Academic Editor: Christophe Chevillard

Copyright © 2014 Isabela Resende Pereira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. C. Ferreira, B. M. Ianni, L. C. J. Abel et al., “Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/“indeterminate” and Chagas disease cardiomyopathy patients,” Memorias do Instituto Oswaldo Cruz, vol. 98, no. 3, pp. 407–411, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Pérez-Fuentes, J. F. Guégan, C. Barnabé et al., “Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals,” International Journal for Parasitology, vol. 33, no. 3, pp. 293–299, 2003. View at Google Scholar
  3. A. Talvani, M. O. C. Rocha, A. L. Ribeiro, R. Correa-Oliveira, and M. M. Teixeira, “Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease,” Journal of Infectious Diseases, vol. 189, no. 2, pp. 214–220, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. R. Pérez, S. D. Silva-Barbosa, L. R. Berbert et al., “Immunoneuroendocrine alterations in patients with progressive forms of chronic Chagas disease,” Journal of Neuroimmunology, vol. 235, no. 1-2, pp. 84–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. R. Sousa, J. A. Gomes, R. C. Fares et al., “Plasma cytokine expression is associated with cardiac morbidity in Chagas disease,” PLoS ONE, vol. 9, no. 3, Article ID e87082, 2014. View at Publisher · View at Google Scholar
  6. A. Rassi Jr., A. Rassi, and J. A. Marin-Neto, “Chagas disease,” The Lancet, vol. 375, no. 9723, pp. 1388–1402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. L. C. J. Abel, L. V. Rizzo, B. Ianni et al., “Chronic Chagas' disease cardiomyopathy patients display an increased IFN-γ response to Trypanosoma cruzi infection,” Journal of Autoimmunity, vol. 17, no. 1, pp. 99–107, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. D. B. Rocha Rodrigues, M. A. dos Reis, A. Romano et al., “In situ expression of regulatory cytokines by heart inflammatory cells in Chagas' disease patients with heart failure.,” Clinical & developmental immunology, vol. 2012, Article ID 361730, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Sliwa, A. Woodiwiss, V. N. Kone et al., “Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study,” Circulation, vol. 109, no. 6, pp. 750–755, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Wong, D. Ziring, Y. Korin et al., “TNFα blockade in human diseases: mechanisms and future directions,” Clinical Immunology, vol. 126, no. 2, pp. 121–136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. P. C. Taylor, “Pharmacology of TNF rheumatoid arthritis and other chronic inflammatory,” Current Opinion in Pharmacology, vol. 10, no. 3, pp. 308–315, 2010. View at Publisher · View at Google Scholar
  12. K. Kroll-Palhares, J. C. Silvério, A. A. Da Silva et al., “TNF/TNFR1 signaling up-regulates CCR5 expression by CD8+ T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-α blockade,” Memorias do Instituto Oswaldo Cruz, vol. 103, no. 4, pp. 375–385, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. S. Aliberti, J. T. Souto, A. P. M. P. Marino et al., “Modulation of chemokine production and inflammatory responses in IFN-γ and TNF-R1 deficient mice during Trypanosoma cruzi infection,” American Journal of Pathology, vol. 158, no. 4, pp. 1433–1440, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Lannes-Vieira, I. R. Pereira, N. F. Vinagre, and L. E. A. Arnez, “TNF-α and TNFR in chagas disease: from protective immunity to pathogenesis of chronic cardiomyopathy,” Advances in Experimental Medicine and Biology, vol. 691, pp. 221–230, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. B. Bilate, V. M. Salemi, F. J. Ramires et al., “TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy,” Microbes and Infection, vol. 9, no. 9, pp. 1104–1113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. R. Pérez, G. H. Fontanella, A. L. Nocito, S. Revelli, and O. A. Bottasso, “Short treatment with the tumour necrosis factor-α blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation,” Clinical and Experimental Immunology, vol. 157, no. 2, pp. 291–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. P. E. A. Souza, M. O. C. Rocha, E. Rocha-Vieira et al., “Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity,” Infection and Immunity, vol. 72, no. 9, pp. 5283–5291, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. C. Silverio, I. R. Pereira, M. D. C. Cipitelli et al., “CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental trypanosoma cruzi-elicited cardiomyopathy,” PLoS Pathogens, vol. 8, no. 4, Article ID e1002645, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Bruns, C. Meinken, P. Schauenberg et al., “Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans,” Journal of Clinical Investigation, vol. 119, no. 5, pp. 1167–1177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Xueyi, C. Lina, W. Zhenbiao, H. Qing, L. Qiang, and P. Zhu, “Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy.,” Journal of clinical immunology, vol. 33, no. 1, pp. 151–161, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Vilar-Pereira, A. A. D. Silva, I. R. Pereira et al., “Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions,” Brain, Behavior, and Immunity, vol. 26, no. 7, pp. 1136–1149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Redlich, S. Hayer, A. Maier et al., “Tumor necrosis factor α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin,” Arthritis and Rheumatism, vol. 46, no. 3, pp. 785–792, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. C. M. E. Carvalho, J. C. Silverio, A. A. da Silva et al., “Inducible nitric oxide synthase in heart tissue and nitric oxide in serum of Trypanosoma cruzi-infected rhesus monkeys: Association with heart injury,” PLoS Neglected Tropical Diseases, vol. 6, no. 5, Article ID e1644, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. G. A. Medeiros, J. C. Silvério, A. P. M. P. Marino et al., “Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage,” Microbes and Infection, vol. 11, no. 2, pp. 264–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. I. R. Pereira, G. Vilar-Pereira, A. A. Silva, and J. Lannes-Vieira, “Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease,” Memórias do Instituto Oswaldo Cruz, vol. 109, no. 3, pp. 289–298, 2014. View at Google Scholar
  26. A. Talvani, C. S. Ribeiro, J. C. S. Aliberti et al., “Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-γ as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi,” Microbes and Infection, vol. 2, no. 8, pp. 851–866, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Truyens, F. Torrico, R. Lucas, P. de Baetselier, W. A. Buurman, and Y. Carlier, “The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi,” Infection and Immunity, vol. 67, no. 11, pp. 5579–5586, 1999. View at Google Scholar · View at Scopus
  28. P. Minoprio, “Parasite polyclonal activators: new targets for vaccination approaches?” International Journal for Parasitology, vol. 31, no. 5-6, pp. 588–591, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. M. D. L. Higuchi, L. A. Benvenuti, M. M. Reis, and M. Metzger, “Pathophysiology of the heart in Chagas' disease: current status and new developments,” Cardiovascular Research, vol. 60, no. 1, pp. 96–107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. P. V. A. dos Santos, E. Roffê, H. C. Santiago et al., “Prevalence of CD8+αβ T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62LLowLFA-1HighVLA-4High activation phenotype and expression of IFN-γ-inducible adhesion and chemoattractant molecules,” Microbes and Infection, vol. 3, no. 12, pp. 971–984, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. F. S. Machado, G. A. Martins, J. C. S. Aliberti, F. L. A. C. Mestriner, F. Q. Cunha, and J. S. Silva, “Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity,” Circulation, vol. 102, no. 24, pp. 3003–3008, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Junqueira, B. Caetano, D. C. Bartholomeu et al., “The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease,” Expert Reviews in Molecular Medicine, vol. 12, article e29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Michailowsky, N. M. Silva, C. D. Rocha, L. Q. Vieira, J. Lannes-Vieira, and R. T. Gazzinelli, “Pivotal role of interleukin-12 and interferon-γ axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection,” The American Journal of Pathology, vol. 159, no. 5, pp. 1723–1733, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Chen and D. V. Goeddel, “TNF-R1 signaling: a beautiful pathway,” Science, vol. 296, no. 5573, pp. 1634–1635, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Castaños-Velez, S. Maerlan, L. M. Osorio et al., “Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice,” Infection and Immunity, vol. 66, no. 6, pp. 2960–2968, 1998. View at Google Scholar · View at Scopus
  36. A. M. Feldman and D. McNamara, “Myocarditis,” The New England Journal of Medicine, vol. 343, no. 19, pp. 1388–1398, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Hamid, Y. Gu, R. V. Ortines et al., “Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-κB and inflammatory activation,” Circulation, vol. 119, no. 10, pp. 1386–1397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. G. S. Ashcroft, M. J. Jeong, J. J. Ashworth et al., “Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing,” Wound Repair and Regeneration, vol. 20, no. 1, pp. 38–49, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. P. M. M. Guedes, V. M. Veloso, L. C. C. Afonso et al., “Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-γ, TNF-α, and low IL-10 production during the acute infection phase,” Veterinary Immunology and Immunopathology, vol. 130, no. 1-2, pp. 43–52, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. D. M. Vitelli-Avelar, R. Sathler-Avelar, A. Teixeira-Carvalho et al., “Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease,” Scandinavian Journal of Immunology, vol. 68, no. 5, pp. 516–525, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Iwakura, H. Ishigame, S. Saijo, and S. Nakae, “Functional specialization of interleukin-17 family members,” Immunity, vol. 34, no. 2, pp. 149–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. A. S. Wareham, J. A. Tree, and P. D. Marsh, “Th17 cells and iron homeostasis in protective immunity against tuberculosis in cynomolgus macaques,” PLoS ONE, vol. 9, no. 2, Article ID e88149, 2014. View at Google Scholar
  43. P. M. da Matta Guedes, F. R. S. Gutierrez, F. L. Maia et al., “IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis.,” PLoS Neglected Tropical Diseases, vol. 4, no. 2, article e604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Hartupee, C. Liu, M. Novotny, X. Li, and T. Hamilton, “IL-17 enhances chemokine gene expression through mRNA stabilization,” Journal of Immunology, vol. 179, no. 6, pp. 4135–4141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Roffê, A. G. Rothfuchs, H. C. Santiago et al., “IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection,” Journal of Immunology, vol. 188, no. 2, pp. 649–660, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Corrêa-Oliveira, J. Gomes, and E. M. Lemos, “The role of the immune response on the development of severe clinical forms of human Chagas disease,” Memórias do Instituto Oswaldo Cruz, vol. 94, supplement 1, pp. 235–253, 1999. View at Google Scholar
  47. D. G. Strauss, S. Cardoso, J. A. C. Lima, C. E. Rochitte, and K. C. Wu, “ECG scar quantification correlates with cardiac magnetic resonance scar size and prognostic factors in Chagas' disease,” Heart, vol. 97, no. 5, pp. 357–361, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. S. G. Andrade, J. B. Magalhães, and A. L. Pontes, “Therapy of the chronic phase of the experimental infection by Trypanosoma cruzi with benzonidazole and nifurtimox,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 22, no. 3, pp. 113–118, 1989. View at Google Scholar
  49. M. de Lourdes Higuchi, S. Fukasawa, T. de Brito, L. C. Parzianello, G. Bellotti, and J. A. F. Ramires, “Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study,” Heart, vol. 82, no. 3, pp. 279–285, 1999. View at Google Scholar · View at Scopus